Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹44,388.50Qualified | L1 | Qualified MSE, Category: General |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
6 Jul 2023, 9:00 pmClosed
MEDICINES
4952596
GEM/2023/B/3619028
Two Packet Bid
NIV,NIV,10115,10116,10301,10314,10742,10871,11032,11638,11758,11840,12525,12711,2011
15 days
Jammu And Kashmir; Poonch
Total value wise evaluation
BOQ
Exempted
6 Jul 2023
26 Jun 2023
6 Jul 2023
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | NIV | Lignocaine 2% without preservative (Xylocard) | 10 | Vial | 425.consignee | 15 |
| 2 | NIV | Inj Etomidate 2mg/ml vial of 10ml | 10 | Vial | 425.consignee | 15 |
| 3 | 10115 | Bupivacaine HCL inj 5% (5mg/ml) vial of 20ml | 30 | Vial | 425.consignee | 15 |
| 4 | 10116 | Bupivacaine HLC inj heavy amp of 4ml, 5mg/ml | 30 | Amp | 425.consignee | 15 |
| 5 | 10301 | Inj Adrenaline Tartrate (1 1000) Amp of 1ml | 250 | Amp | 425.consignee | 15 |
| 6 | 10314 | Inj Hydrocortisone sodium succinate 100mg in vial | 250 | Vial | 425.consignee | 15 |
| 7 | 10742 | Fentanyl 25mcg Trans dermal | 15 | No | 425.consignee | 15 |
| 8 | 10871 | Ondansetron inj 2mg/ml 4ml injection | 450 | Amp | 425.consignee | 15 |
| 9 | 11032 | Inj Tranexamic Acid 500mg/5ml | 100 | Amp | 425.consignee | 15 |
| 10 | 11638 | Inj Pantoprazole 40mg | 1,000 | Vial | 425.consignee | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_4952596.pdf
GEM_BID
boq_2023-06-26-19-54-35_01d46a5ff7706cfee6a88410e76bbe8e.pdf
BOQ
boq_item_sample_file_2023-06-26-19-54-35_222c96640cc9ada265a0d130a0425591.csv
BOQ
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .